vs

Side-by-side financial comparison of Baird Medical Investment Holdings Ltd (BDMD) and PROVIDENT FINANCIAL HOLDINGS INC (PROV). Click either name above to swap in a different company.

PROVIDENT FINANCIAL HOLDINGS INC is the larger business by last-quarter revenue ($9.8M vs $8.0M, roughly 1.2× Baird Medical Investment Holdings Ltd). PROVIDENT FINANCIAL HOLDINGS INC runs the higher net margin — 14.6% vs -142.7%, a 157.3% gap on every dollar of revenue. PROVIDENT FINANCIAL HOLDINGS INC produced more free cash flow last quarter ($1.0M vs $-3.2M).

Baird Medical Investment Holdings Ltd is a healthcare-focused investment holding company mainly operating in the Chinese market. It invests in and manages businesses covering in vitro diagnostic devices, medical consumables, and community healthcare services, serving clinical institutions and individual consumers.

Provident Financial Holdings Inc is a bank holding company operating through its subsidiary Provident Savings Bank. It offers retail and commercial banking services including deposit products, mortgage loans, consumer lending and small business financing for local communities across California.

BDMD vs PROV — Head-to-Head

Bigger by revenue
PROV
PROV
1.2× larger
PROV
$9.8M
$8.0M
BDMD
Higher net margin
PROV
PROV
157.3% more per $
PROV
14.6%
-142.7%
BDMD
More free cash flow
PROV
PROV
$4.3M more FCF
PROV
$1.0M
$-3.2M
BDMD

Income Statement — Q2 FY2025 vs Q2 FY2026

Metric
BDMD
BDMD
PROV
PROV
Revenue
$8.0M
$9.8M
Net Profit
$-11.4M
$1.4M
Gross Margin
82.1%
Operating Margin
-131.3%
20.8%
Net Margin
-142.7%
14.6%
Revenue YoY
2.5%
Net Profit YoY
64.7%
EPS (diluted)
$0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BDMD
BDMD
PROV
PROV
Q4 25
$9.8M
Q3 25
$9.7M
Q2 25
$8.0M
$9.8M
Q1 25
$10.1M
Q4 24
$9.6M
Q3 24
$9.5M
Q2 24
$9.9M
Q1 24
$9.4M
Net Profit
BDMD
BDMD
PROV
PROV
Q4 25
$1.4M
Q3 25
$1.7M
Q2 25
$-11.4M
$1.6M
Q1 25
$1.9M
Q4 24
$872.0K
Q3 24
$1.9M
Q2 24
$2.0M
Q1 24
$1.5M
Gross Margin
BDMD
BDMD
PROV
PROV
Q4 25
Q3 25
Q2 25
82.1%
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
BDMD
BDMD
PROV
PROV
Q4 25
20.8%
Q3 25
28.1%
Q2 25
-131.3%
23.6%
Q1 25
26.2%
Q4 24
12.7%
Q3 24
28.3%
Q2 24
27.8%
Q1 24
22.5%
Net Margin
BDMD
BDMD
PROV
PROV
Q4 25
14.6%
Q3 25
17.3%
Q2 25
-142.7%
16.7%
Q1 25
18.4%
Q4 24
9.1%
Q3 24
20.0%
Q2 24
19.7%
Q1 24
15.9%
EPS (diluted)
BDMD
BDMD
PROV
PROV
Q4 25
$0.22
Q3 25
$0.25
Q2 25
$0.24
Q1 25
$0.28
Q4 24
$0.13
Q3 24
$0.28
Q2 24
$0.28
Q1 24
$0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BDMD
BDMD
PROV
PROV
Cash + ST InvestmentsLiquidity on hand
$54.4M
Total DebtLower is stronger
$8.4M
Stockholders' EquityBook value
$35.6M
$127.5M
Total Assets
$77.0M
$1.2B
Debt / EquityLower = less leverage
0.24×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BDMD
BDMD
PROV
PROV
Q4 25
$54.4M
Q3 25
$49.4M
Q2 25
$53.1M
Q1 25
$50.9M
Q4 24
$45.5M
Q3 24
$48.2M
Q2 24
$51.4M
Q1 24
$51.7M
Total Debt
BDMD
BDMD
PROV
PROV
Q4 25
Q3 25
Q2 25
$8.4M
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
BDMD
BDMD
PROV
PROV
Q4 25
$127.5M
Q3 25
$128.4M
Q2 25
$35.6M
$128.5M
Q1 25
$128.9M
Q4 24
$128.6M
Q3 24
$129.6M
Q2 24
$129.9M
Q1 24
$129.5M
Total Assets
BDMD
BDMD
PROV
PROV
Q4 25
$1.2B
Q3 25
$1.2B
Q2 25
$77.0M
$1.2B
Q1 25
$1.3B
Q4 24
$1.3B
Q3 24
$1.3B
Q2 24
$1.3B
Q1 24
$1.3B
Debt / Equity
BDMD
BDMD
PROV
PROV
Q4 25
Q3 25
Q2 25
0.24×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BDMD
BDMD
PROV
PROV
Operating Cash FlowLast quarter
$-3.2M
$1.2M
Free Cash FlowOCF − Capex
$-3.2M
$1.0M
FCF MarginFCF / Revenue
-40.7%
10.5%
Capex IntensityCapex / Revenue
0.6%
1.9%
Cash ConversionOCF / Net Profit
0.85×
TTM Free Cash FlowTrailing 4 quarters
$14.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BDMD
BDMD
PROV
PROV
Q4 25
$1.2M
Q3 25
$2.5M
Q2 25
$-3.2M
$8.7M
Q1 25
$3.3M
Q4 24
$324.0K
Q3 24
$2.6M
Q2 24
$5.7M
Q1 24
$3.0M
Free Cash Flow
BDMD
BDMD
PROV
PROV
Q4 25
$1.0M
Q3 25
$2.5M
Q2 25
$-3.2M
$8.2M
Q1 25
$3.3M
Q4 24
$307.0K
Q3 24
$2.4M
Q2 24
$4.1M
Q1 24
$2.6M
FCF Margin
BDMD
BDMD
PROV
PROV
Q4 25
10.5%
Q3 25
25.2%
Q2 25
-40.7%
83.5%
Q1 25
32.5%
Q4 24
3.2%
Q3 24
25.1%
Q2 24
41.3%
Q1 24
27.5%
Capex Intensity
BDMD
BDMD
PROV
PROV
Q4 25
1.9%
Q3 25
0.5%
Q2 25
0.6%
5.4%
Q1 25
0.3%
Q4 24
0.2%
Q3 24
1.8%
Q2 24
16.0%
Q1 24
4.2%
Cash Conversion
BDMD
BDMD
PROV
PROV
Q4 25
0.85×
Q3 25
1.48×
Q2 25
5.34×
Q1 25
1.79×
Q4 24
0.37×
Q3 24
1.35×
Q2 24
2.91×
Q1 24
2.00×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons